Long-term effects of statins on arterial pressure and stiffness of hypertensives
Open Access
- 9 September 2004
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Journal of Human Hypertension
- Vol. 19 (2), 103-109
- https://doi.org/10.1038/sj.jhh.1001786
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial TreeStroke, 2002
- Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary studyJournal of Human Hypertension, 2002
- Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive PatientsHypertension, 2002
- Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive PatientHypertension, 2001
- HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen SpeciesHypertension, 2001
- Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbitsAtherosclerosis, 2001
- Inhibitory Effects of Fluvastatin and Its Metabolites on Hydrogen Peroxide-Induced Oxidative Destruction of Hemin and Low-Density Lipoprotein.Biological & Pharmaceutical Bulletin, 2000
- Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)The American Journal of Cardiology, 1999
- Aortic Pulse Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive PatientsHypertension, 1999
- Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatinAtherosclerosis, 1997